Merck Sharp + Dohme Corp.

Telefonaktiebolaget Lm Ericsson (publ)

Rhodia Operations

Tyco Electronics (shanghai) Co., Ltd.

Chinese Academy of Sciences

Other

Baoshan Iron & Steel Co., Ltd.

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Medshine Discovery Inc.

General Electric Company

Honeywell International Inc.

Via Alliance Semiconductor Co., Ltd.

Nio Nextev Limited

Cspc Zhongqi Pharmaceutical Technology (shijiazhuang) Co., Ltd.

Chengdu Tianma Micro-electronics Co., Ltd.

Peng Li

Shuhui Chen

Jian Li

Haiying He

Xuanjia Peng

Anandan Palani

Xing Dai

Shuwen He

Zhi Luo

Ravi P Nargund

Dong Xiao

Casey Cameron McComas

Hong Liu

Richard Soll

Qun Dang

Xiaolin Li

Hao Wu

Guoping Hu

Kevin X Chen

Jian Xiong

Xiaoxin Chen

Chaofeng Long

Lizhang Yang

Nigel J Liverton

Cheng Wang

Frank Narjes

Uwe Koch

Yang Liu

Xinyu Zhang

Clare London

Linda Brockunier

Bin Wei

Magnus Hallenstål

Fei Wang

Tao Guo

Zheng Wang

Bo Wu

Bin He

Fei Sun

Wei Wei

Ke Liu

Rong Zhang

Zhengxia Chen

Wei Xiao

Nicolas Zorn

Cheng Xie

Zhong Lai

Jingjing Wang

Yugang Li

Feng Tang

Xiangzhao Wang

Floryan Decampo

Joerg Habermann

Song Xue

Lele Yang

Pascal Metivier

Zhuowei Liu

Ning Li

Yaxun Yang

Yunjun Lu

Haowei Yang

Armin T Liebens

Karen M Marcantonio

Hualing Xiao

Changzhe Peng

Fei Hao

Zhicheng Ding

Weidong Li

Maria Cruz Bartolome Rodrigo

Xiaowei Zhang

Jianfei Wang

Jikui Sun

Yingru Hu

Meibi Dai

Zhongding Liu

Jeffrey Francis Wessels

Volker Kleinfeld

Weiwei Mao

Hui Hu

Guibai Liang

Hongxing Chen

Feng Shi

Mark Joseph Gleason

Bailing Yang

Jiangpeng Liao

Xiukuan Yang

Yuezhong Tan

Haitao Duan

Guangwen Yang

Dongquan Hou

Qiu Li

Hangkong Yuan

Zhangwei Wang

Xiaojun Yin

Chunyan Du

Hua Ni

Zhaohui Zhuang

Disclosed are a class of compounds having a highly selective inhibition of ROS1, and the use thereof in the preparation of drugs for treating diseases related to abnormal ROS1 kinase expression. Specifically disclosed are compounds represented by formula (IV) and a pharmaceutically acceptable salt thereof.

Compound as highly selective ROS1 inhibitor and use thereof

Provided is an aldehyde binder, specifically, disclosed is a compound as represented by formula (II) or a pharmaceutically acceptable salt.

Compound for use in retinal diseases

A crystal form of a pyridinylphenyl compound and a preparation method therefor. Use of the crystal form in the preparation of a medicament of treating related diseases is also comprised.

Crystal form of pyridinylphenyl compound and preparation method therefor

An early-warning system, method, and apparatus for steering of a two-wheeled vehicle, and a corresponding two-wheeled vehicle including a display apparatus. The system includes: a first control system and a second control system both operating independently and exchanging data between each other in real time; the first control system is configured to: monitor a steering state of the two-wheeled vehicle in real time and generate steering state data; generate early-warning state data based on the steering state data; transmit at least part of the steering state data and the early-warning state data to the second control system in real time; and control corresponding components of the two-wheeled vehicle to operate according to control instructions received from the second control system and internal preset instructions; and the second control system is configured to: control a display of the display apparatus based on the steering state data and/or the early-warning information.

Early-warning system, method and device for steering of two-wheeled vehicle, and corresponding two-wheeled vehicle

Embodiments of the present disclosure provide methods and apparatuses for service management. A method at a service communication proxy (SCP) comprises receiving a first request for creating a service entry, wherein the first request includes at least one parameter to build the service entry context. The method further comprises creating the service entry based on the parameters in the first request. The method further comprises applying the service entry to process a service request from a network function (NF) consumer.

Method and apparatus for service management

A compound represented by formula (I), isomers or pharmaceutically acceptable salts thereof, and application thereof in the preparation of drugs for treating diseases related to RIP-1 (receptor interacting protein) kinase.

Bicyclic compound as RIP-1 kinase inhibitor and application thereof

The present invention discloses a class of anti-influenza virus compounds, and the use thereof in the preparation of a drug for treating diseases associated with influenza viruses. In particular, the present invention discloses a compound represented by formula (I) and a pharmaceutically acceptable salt thereof.

Anti-influenza virus pyrimidine derivatives

Embodiments of the present disclosure provide methods and apparatuses for flow control. A method at a service communication proxy (SCP) comprises creating a flow table entry including a match field and an instruction field. The method further comprises applying the flow table entry to match and process a service request from a network function (NF) consumer, wherein the service request may be to be served by a NF producer.

Method and apparatus for flow control

Disclosed are a solid form, a crystalline form, and crystal form A of a compound of formula (I) used as an FXR agonist, and a preparation method therefor. Also comprised is an application of the compound of formula (I) in preparation of a medication for treating nonalcoholic steatohepatitis (NASH).

Solid form, crystalline form, and crystal form a of FXR agonist, and preparation method and application thereof

Disclosed are a ring-modified proline short peptide compound and the use thereof, and specifically disclosed is a compound represented by formula (X) or a pharmaceutically acceptable salt thereof.

Ring-modified proline short peptide compound and use thereof

Disclosed are a process route of a compound of a compound of formula (IV), a crystal form and a preparation method therefor. Also disclosed is an application of the crystal form in preparation of drugs for treating diseases associated with SSAO.

Process route of compound of formula (IV), crystal form and preparation method therefor

Embodiments of the present disclosure provide methods and apparatuses for service discovery. The method may comprise sending a first service discovery request including forward information indicating that the first service discovery request has been processed by one or more network function repository nodes to a second network function repository node; and receiving a first service discovery response from the second network function repository node.

Method and apparatus for service discovery

A method performed by a function in a network node in a telecommunications network having at least one service communication proxy, SCP, deployed between a first network node and a second network node. The method includes receiving a request for routing information to signal a message from the first network node to the second network node. The method further includes responsive to the request from the first network node, providing a response to a network node that sent the request wherein the response identifies at least a portion of a routing path for the message based on a routing path configuration.

Routing communication in telecommunications network having multiple service communication proxies

Embodiments of the present disclosure provide methods, apparatus and computer program products for service discovery. A method implemented at a primary Network-Function Repository Function, NRF, in a communication network, wherein the communication network comprising at least one primary NRF and at least one secondary NRFs, the method comprising: receiving a discovery request from a first secondary NRF, wherein the discovery request comprises a service query information for a target Network Function, NF, obtaining target NF information, providing the target NF information to the first secondary NRF.

Growing community of inventors

Shanghai, China

Peng Li